Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen (Q39650011)
Jump to navigation
Jump to search
scientific article published on 30 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen |
scientific article published on 30 September 2010 |
Statements
1 reference
Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen (English)
1 reference
Toshihiko Wakabayashi
1 reference
Atsushi Natsume
1 reference
Kazuya Motomura
1 reference
Masasuke Ohno
1 reference
Ken Ichiro Iwami
1 reference
Hidetaka Iwamizu
1 reference
Kana Noritake
1 reference
Daiki Ito
1 reference
Yuki Toi
1 reference
Motokazu Ito
1 reference
Jun Yoshida
1 reference
Kazuhiro Yoshikawa
1 reference
30 September 2010
1 reference
1 reference
2518-2524
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference